Cirrhosis/Liver Failure News

LAS VEGAS — In this video exclusive, Kevin Moore, MD, discussed a study assessing real-world outcomes in patients with esophageal variceal hemorrhage and liver cirrhosis treated with terlipressin.

LAS VEGAS – In this video exclusive, Nancy S. Reau, MD, FAASLD, AGAF, discussed the Liver Health Annual Trends Report, which was launched during a panel discussion hosted by Salix Pharmaceuticals at the ACG Annual Scientific Meeting.

LAS VEGAS — No safety and efficacy concerns for COVID-19 messenger RNA vaccines were noted among patients with cirrhosis compared with the general population, according to a presentation at the ACG Annual Scientific Meeting.

LAS VEGAS – In this video exclusive, Donna Cryer, JD, founder, president and CEO Global Liver Institute, spoke on the launch of the Liver Health Annual Trends Report and its possible impact for patients with chronic liver disease.

A speaker at the American Nephrology Nurses Association’s Nephrology Nursing Practice, Management & Leadership Conference discussed the development of AKI in patients who have hepatorenal syndrome or who use acetaminophen therapies.

A cohort of veterans with cirrhosis who received the mRNA COVID-19 vaccine had a delayed and modest decrease in infection, with an excellent decrease in hospitalizations or death.

For patients with severe COVID-19, cholangiopathy was a late complication with potential for progressive biliary injury or liver failure, according to a study published in the American Journal of Gastroenterology.

Healio Gastroenterology presents the following reports on recent news in COVID-19.

Healio Gastroenterology presents the following report on the top peer-tested stories in June.

Among patients hospitalized with COVID-19, liver impairment appeared within the first days of admission; virus severity also correlated with abnormality in liver function tests.